Arrive AI (ARAI) disclosed Tuesday the issuance of a new US patent for an artificial intelligence-based platform, expanding its capabilities by enabling temperature-controlled heating and cooling for precision handling.
Shares nearly doubled as intraday trading volume catapulted to over 36.2 million from a daily average of about 354,000.
Evogene (EVGN) reported Tuesday the completion of its generative AI foundation model for small molecule design, developed in collaboration with Google Cloud, part of Alphabet (GOOG, GOOGL).
Shares soared 95% as intraday trading volume soared to over 93.7 million from a daily average of roughly 374,000.
Gelteq (GELS) reported Tuesday the expansion of its US commercial strategy via an exclusive logistics and distribution agreement with Healthy Extracts, a firm focused on producing plant-based health supplements.
Shares jumped 60% as intraday trading volume advanced to more than 72.4 million from a daily average of about 1.5 million.
Price: 12.53, Change: +6.24, Percent Change: +99.05
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.